625 related articles for article (PubMed ID: 12807228)
1. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
[TBL] [Abstract][Full Text] [Related]
2. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
Marcickiewicz J; Brännström M
Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
[TBL] [Abstract][Full Text] [Related]
3. [Malignant ovarian germ cell tumours: a trial of 36 cases].
Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of 27 ovarian tumors of low malignant potential.
Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
[TBL] [Abstract][Full Text] [Related]
5. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
6. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
7. [Results of fertility preserving operations in malignant ovarian tumors].
Kleine W
Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
[TBL] [Abstract][Full Text] [Related]
8. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
9. [Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].
Liu Q; Ding XL; Yang JX; Cao DY; Shen K; Lang JH; Zhang GN; Xin XY; Xie X; Zhang SL; Wu YM; Zhu GH; Wang J; Chen YL; Kong BH; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):188-92. PubMed ID: 23849941
[TBL] [Abstract][Full Text] [Related]
10. Malignant ovarian germ-cell tumours.
Low JJ; Ilancheran A; Ng JS
Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):347-55. PubMed ID: 22301054
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcomes after conservative surgical management of ovarian neoplasms treated at a single institution.
Smaldone GM; Richard SD; Edwards RP
Int J Gynecol Cancer; 2010 Aug; 20(6):926-31. PubMed ID: 20683397
[TBL] [Abstract][Full Text] [Related]
12. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
[TBL] [Abstract][Full Text] [Related]
13. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
Tangir J; Zelterman D; Ma W; Schwartz PE
Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
[TBL] [Abstract][Full Text] [Related]
14. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
Schilder JM; Thompson AM; DePriest PD; Ueland FR; Cibull ML; Kryscio RJ; Modesitt SC; Lu KH; Geisler JP; Higgins RV; Magtibay PM; Cohn DE; Powell MA; Chu C; Stehman FB; van Nagell J
Gynecol Oncol; 2002 Oct; 87(1):1-7. PubMed ID: 12468335
[TBL] [Abstract][Full Text] [Related]
15. Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.
Ghalleb M; Bouzaiene H; Slim S; Hadiji A; Hechiche M; Ben Hassouna J; Rahal K
J Med Case Rep; 2017 Dec; 11(1):350. PubMed ID: 29248013
[TBL] [Abstract][Full Text] [Related]
16. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
[TBL] [Abstract][Full Text] [Related]
17. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
18. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
Wang P; Fang L
World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
[TBL] [Abstract][Full Text] [Related]
19. Outcomes after Fertility-sparing Surgery for Women with Ovarian Cancer: A Systematic Review of the Literature.
Bercow A; Nitecki R; Brady PC; Rauh-Hain JA
J Minim Invasive Gynecol; 2021 Mar; 28(3):527-536.e1. PubMed ID: 32861046
[TBL] [Abstract][Full Text] [Related]
20. Fertility after the treatment of gynecologic tumors.
Kesic V
Recent Results Cancer Res; 2008; 178():79-95. PubMed ID: 18080446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]